Bristol-Myers Squibb | BMY - Passività Correnti

Prezzo Delle Azioni
58.66
Cambio Giornaliero
-1.93 -3.19%
Mensile
-1.58%
Annuale
16.00%
Q2 Previsione
57.45




Passività Correnti Cambiamento Data
AbbVie USD 43.29B 3.9B 2025-12
Abbott USD 18.38B 1.88B 2026-03
ALKERMES USD 543.44M 69.08M 2025-12
Amgen USD 24.96B 534M 2026-03
AstraZeneca USD 32.57B 1.95B 2026-03
Biogen USD 3B 350.5M 2026-03
Bristol-Myers Squibb USD 19.16B 4.26B 2026-03
Coherus Biosciences USD 140.39M 231.91M 2025-12
Drreddys Laboratories INR 1.76B 62.5M 2025-12
Eli Lilly USD 36.63B 1.41B 2026-03
Gilead Sciences USD 11.81B 485M 2025-12
GlaxoSmithKline GBP 22.43B 1.04B 2026-03
J&J USD 57.72B 3.59B 2026-03
Medtronic USD 9.5B 440M 2025-12
Merck USD 28.33B 301M 2025-12
Novartis USD 27.28B 4.72B 2025-12
Novo Nordisk DKK 215.66B 18.7B 2025-12
Perrigo USD 1.01B 132.4M 2025-12
Pfizer USD 36.6B 1.13B 2025-09
Phibro Animal Health USD 282.37M 12.23M 2025-12
Prestige Brands USD 139.56M 4.95M 2025-12
Regeneron Pharmaceuticals USD 5.11B 739.3M 2026-03
Roche Holding CHF 28B 421M 2025-12
Sanofi EUR 30.01B 1.66B 2026-03
Sanofi EUR 28.35B 9.32B 2025-12
United Therapeutics USD 560.6M 14.3M 2025-12
Zoetis USD 2.24B 428M 2025-12